213 related articles for article (PubMed ID: 31202992)
1. Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.
Li H; Gao X; Huang X; Wang X; Xu S; Uchita T; Gao M; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Sep; 178():446-457. PubMed ID: 31202992
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen sulfide releasing oridonin derivatives induce apoptosis through extrinsic and intrinsic pathways.
Li H; Mu J; Sun J; Xu S; Liu W; Xu F; Li Z; Xu J; Hua H; Li D
Eur J Med Chem; 2020 Feb; 187():111978. PubMed ID: 31877536
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide releasing enmein-type diterpenoid derivatives as apoptosis inducers through mitochondria-related pathways.
Xu F; Gao X; Li H; Xu S; Li X; Hu X; Li Z; Xu J; Hua H; Li D
Bioorg Chem; 2019 Feb; 82():192-203. PubMed ID: 30326401
[TBL] [Abstract][Full Text] [Related]
4. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
5. Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation.
Hu X; Bai Z; Qiao J; Li H; Xu S; Wang X; Xu Y; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Jun; 171():169-179. PubMed ID: 30921757
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells.
Li D; Cai H; Jiang B; Liu G; Wang Y; Wang L; Yao H; Wu X; Sun Y; Xu J
Eur J Med Chem; 2013 Jan; 59():322-8. PubMed ID: 23274570
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Cytotoxicity and Antimicrobial Activity of New Enmein-type Kauranoid Diterpenoid Derivatives.
Li D; Han T; Hu X; Tian K; Xu S; Zhou T; Cheng K; Li Z; Hua H; Xu J
Anticancer Agents Med Chem; 2017; 17(12):1679-1688. PubMed ID: 28403782
[TBL] [Abstract][Full Text] [Related]
8. Bioactive Natural Spirolactone-Type 6,7-
Li H; Jiao R; Mu J; Xu S; Li X; Wang X; Li Z; Xu J; Hua H; Li D
Molecules; 2018 Nov; 23(11):. PubMed ID: 30413071
[TBL] [Abstract][Full Text] [Related]
9. Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
Gao X; Li J; Wang M; Xu S; Liu W; Zang L; Li Z; Hua H; Xu J; Li D
Eur J Med Chem; 2018 Feb; 146():588-598. PubMed ID: 29407983
[TBL] [Abstract][Full Text] [Related]
10. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
11. Oridonin derivatives as potential anticancer drug candidates triggering apoptosis through mitochondrial pathway in the liver cancer cells.
Luo D; Yi Y; Peng K; Liu T; Yang J; Liu S; Zhao W; Qu X; Yu W; Gu Y; Wan S
Eur J Med Chem; 2019 Sep; 178():365-379. PubMed ID: 31200238
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
Hou W; Fan Q; Su L; Xu H
Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.
Ke Y; Liang JJ; Hou RJ; Li MM; Zhao LF; Wang W; Liu Y; Xie H; Yang RH; Hu TX; Wang JY; Liu HM
Eur J Med Chem; 2018 Sep; 157():1249-1263. PubMed ID: 30193221
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel oridonin analogues as potent anticancer agents.
Shen QK; Chen ZA; Zhang HJ; Li JL; Liu CF; Gong GH; Quan ZS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):324-333. PubMed ID: 29303372
[TBL] [Abstract][Full Text] [Related]
15. Induction of the mitochondria-mediated apoptosis in human esophageal cancer cells by DS2, a newly synthetic diterpenoid analog, is regulated by Bax and caused by generation of reactive oxygen species.
Ma YC; Ke Y; Zi X; Zhao F; Yuan L; Zhu YL; Fan XX; Zhao NM; Li QY; Qin YH; Liu HM
Oncotarget; 2016 Dec; 7(52):86211-86224. PubMed ID: 27863415
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, cytotoxicity and antiplasmodial activity of novel ent-kaurane derivatives.
Batista R; García PA; Castro MA; Miguel Del Corral JM; Speziali NL; de P Varotti F; de Paula RC; García-Fernández LF; Francesch A; San Feliciano A; de Oliveira AB
Eur J Med Chem; 2013 Apr; 62():168-76. PubMed ID: 23353738
[TBL] [Abstract][Full Text] [Related]
17. Spirolactone-type and enmein-type derivatives as potential anti-cancer agents derived from oridonin.
Ni X; He C; Jia Y; Wu X; Zhou K; Xu S; Xu J; Yao H
Bioorg Med Chem; 2022 Oct; 72():116977. PubMed ID: 36037626
[TBL] [Abstract][Full Text] [Related]
18. Oridonin, a Promising ent-Kaurane Diterpenoid Lead Compound.
Li D; Han T; Liao J; Hu X; Xu S; Tian K; Gu X; Cheng K; Li Z; Hua H; Xu J
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563888
[TBL] [Abstract][Full Text] [Related]
19. Bioactive enmein-type 6,7-seco-ent-kaurane diterpenoids: natural products, synthetic derivatives and apoptosis related mechanism.
Li H; Sun B; Wang M; Hu X; Gao X; Xu S; Xu Y; Xu J; Hua H; Li D
Arch Pharm Res; 2018 Nov; 41(11):1051-1061. PubMed ID: 30242610
[TBL] [Abstract][Full Text] [Related]
20. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.
Li D; Xu S; Cai H; Pei L; Zhang H; Wang L; Yao H; Wu X; Jiang J; Sun Y; Xu J
Eur J Med Chem; 2013 Jun; 64():215-21. PubMed ID: 23644204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
